Publication | Closed Access

Thymoquinone-rich fraction nanoemulsion (TQRFNE) decreases Aβ40 and Aβ42 levels by modulating APP processing, up-regulating IDE and LRP1, and down-regulating BACE1 and RAGE in response to high fat/cholesterol diet-induced rats

Molecular PharmacologyApp ProcessingOxysterolBiochemistryMedicineLipid PeroxidationNeuropharmacologyAβ42 LevelsLipid ScienceDegenerative PathologyPharmacologyThymoquinone-rich Fraction Nanoemulsion